EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma
Thymic carcinoma is an aggressive malignancy that can be challenging to distinguish from thymoma using histomorphology. We assessed two emerging markers for these entities, EZH2 and POU2F3, and compared them with conventional immunostains. Whole slide sections of 37 thymic carcinomas, 23 type A thym...
Main Authors: | Julia R. Naso, Julie A. Vrana, Justin W. Koepplin, Julian R. Molina, Anja C. Roden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/8/2274 |
Similar Items
-
Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases
by: Xuxia Shen, et al.
Published: (2018-06-01) -
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma
by: Koichiro Kanamori, et al.
Published: (2023-04-01) -
Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma
by: Jae-Han Jeong, et al.
Published: (2020-07-01) -
Imaging Evaluation of Thymoma and Thymic Carcinoma
by: Chad D. Strange, et al.
Published: (2022-01-01) -
Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019
by: Tiemo Sven Gerber, et al.
Published: (2024-01-01)